Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05071807Phase 2Completed
Phase 2, randomised, open-label trial (2 arms), sponsored by The Pennsylvania State University. Primary endpoint: Flow Mediated Dilation at 12 weeks. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05071807.